Business Description
Fresenius Medical Care AG
NAICS : 621492
SIC : 8092
ISIN : US3580291066
Share Class Description:
FMS: ADRCompare
Compare
Traded in other countries / regions
FME.GermanyFMS.USA0H9X.UKFME.Austria1FME.ItalyFMSC34.BrazilFME N.Mexico IPO Date
1996-09-17Description
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 0.75 | |||||
| Debt-to-EBITDA | 4.64 | |||||
| Interest Coverage | 3.96 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.74 | |||||
| Beneish M-Score | -2.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.1 | |||||
| 3-Year EBITDA Growth Rate | -3.4 | |||||
| 3-Year EPS without NRI Growth Rate | -13.3 | |||||
| 3-Year FCF Growth Rate | 1 | |||||
| 3-Year Book Growth Rate | 4.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 23.87 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.13 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.49 | |||||
| 9-Day RSI | 46.25 | |||||
| 14-Day RSI | 47.72 | |||||
| 3-1 Month Momentum % | 4.63 | |||||
| 6-1 Month Momentum % | 27.14 | |||||
| 12-1 Month Momentum % | 26.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 1.03 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 54.03 | |||||
| Days Sales Outstanding | 68.32 | |||||
| Days Payable | 21.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.83 | |||||
| Dividend Payout Ratio | 0.53 | |||||
| 3-Year Dividend Growth Rate | -3.9 | |||||
| Forward Dividend Yield % | 2.83 | |||||
| 5-Year Yield-on-Cost % | 2.79 | |||||
| Shareholder Yield % | 12.24 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.6 | |||||
| Operating Margin % | 8.33 | |||||
| Net Margin % | 2.78 | |||||
| FCF Margin % | 9.32 | |||||
| ROE % | 3.86 | |||||
| ROA % | 1.6 | |||||
| ROIC % | 3.64 | |||||
| 3-Year ROIIC % | 24.98 | |||||
| ROC (Joel Greenblatt) % | 16.47 | |||||
| ROCE % | 5.29 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.93 | |||||
| Forward PE Ratio | 8.61 | |||||
| PE Ratio without NRI | 19.08 | |||||
| Shiller PE Ratio | 11.21 | |||||
| Price-to-Owner-Earnings | 4.5 | |||||
| PS Ratio | 0.71 | |||||
| PB Ratio | 0.93 | |||||
| Price-to-Free-Cash-Flow | 7.42 | |||||
| Price-to-Operating-Cash-Flow | 5.68 | |||||
| EV-to-EBIT | 15.49 | |||||
| EV-to-Forward-EBIT | 11.16 | |||||
| EV-to-EBITDA | 9.6 | |||||
| EV-to-Forward-EBITDA | 6.79 | |||||
| EV-to-Revenue | 1.18 | |||||
| EV-to-Forward-Revenue | 1.15 | |||||
| EV-to-FCF | 13.57 | |||||
| Price-to-GF-Value | 1.17 | |||||
| Price-to-Projected-FCF | 0.46 | |||||
| Price-to-Median-PS-Value | 0.59 | |||||
| Earnings Yield (Greenblatt) % | 6.46 | |||||
| FCF Yield % | 14.51 | |||||
| Forward Rate of Return (Yacktman) % | 3.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:FMS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fresenius Medical Care AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20,873.129 | ||
| EPS (TTM) ($) | 0.997 | ||
| Beta | 1.01 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.21 | ||
| Volatility % | 25.03 | ||
| 14-Day RSI | 47.72 | ||
| 14-Day ATR ($) | 0.476019 | ||
| 20-Day SMA ($) | 23.8695 | ||
| 12-1 Month Momentum % | 26.08 | ||
| 52-Week Range ($) | 17.93 - 25.25 | ||
| Shares Outstanding (Mil) | 586.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fresenius Medical Care AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fresenius Medical Care AG Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fresenius Medical Care AG Frequently Asked Questions
What is Fresenius Medical Care AG(FMS)'s stock price today?
The current price of FMS is $22.86. The 52 week high of FMS is $25.25 and 52 week low is $17.93.
When is next earnings date of Fresenius Medical Care AG(FMS)?
The next earnings date of Fresenius Medical Care AG(FMS) is 2025-05-06.
Does Fresenius Medical Care AG(FMS) pay dividends? If so, how much?
The Dividend Yield %  of Fresenius Medical Care AG(FMS) is 2.83% (As of Today), Highest Dividend Payout Ratio of Fresenius Medical Care AG(FMS) was 0.53. The lowest was 0.22. And the median was 0.3. The  Forward Dividend Yield % of Fresenius Medical Care AG(FMS) is 2.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers